A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 20 (3) , 201-219
- https://doi.org/10.1016/j.pupt.2006.02.001
Abstract
No abstract availableKeywords
This publication has 208 references indexed in Scilit:
- Relationship between exhaled nitric oxide and atopy in Asian young adultsRespirology, 2005
- The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthmaJournal of Allergy and Clinical Immunology, 2004
- Omalizumab is effective in the long-term control of severe allergic asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Oxidant stress in asthmaThorax, 2000
- The mechanism of exercise-induced asthma is …Journal of Allergy and Clinical Immunology, 2000
- Validation of assays for inflammatory mediators in sputumEuropean Respiratory Journal, 2000
- Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammationJournal of Allergy and Clinical Immunology, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroidClinical and Experimental Allergy, 1992